BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 26, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 13, 2018
View Archived Issues
Researchers present Fol-PRI-002 as a potential prodrug for oral administration
Read More
Uncovering the function of Cep57 in mosaic-variegated aneuploidy syndrome
Read More
MMP23B identified as a putative diagnostic biomarker of bladder cancer
Read More
Alnylam's RNAi therapeutic Onpattro for polyneuropathy of hATTR amyloidosis receives first approval
Read More
Pfizer describes new monoglyceride lipase inhibitors
Read More
University of Sydney and University of Technology, Sydney patent glycine transport inhibitors
Read More
Discovery of a potent and selective receptor antagonist for the treatment of asthma
Read More
FDA approves Galafold for Fabry disease
Read More
Orphazyme's arimoclomol enters phase III study for ALS
Read More
Jiangsu Chia Tai Tianqing Pharmaceutical Group, Medshine Discovery identify caspase inhibitors
Read More
MAP3K5 inhibitors identified by Fujian Cosunter Pharmaceutical Co., Medshine Discovery
Read More
Preventing fat uptake by lymphatic system could be antiobesity approach
Read More
TRK fusions actionable in blood cancers
Read More
Controlling HIV's reservoir
Read More
Progranulin as a novel therapeutic target for the treatment of frontotemporal dementia
Read More
Researchers identify novel candidate genes involved in cognitive function
Read More
PARP inhibitors may be ALS drugs
Read More
FDA approves The Population Council's 1-year contraceptive Annovera
Read More
Samsung Bioepis to soon begin phase I study of SB-26
Read More
First patients imaged in phase II expanded access study of 68Ga-PSMA-11
Read More
Iterum Therapeutics initiates phase III testing of sulopenem etzadroxil
Read More
